SINOHEALTH TECH (02361) · Company profile · Eqvero

SINOHEALTH TECH

02361HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	419.09 m CNY	403.73 m CNY	396.19 m CNY	356.67 m CNY	324.17 m CNY
Cost of revenue	161.49 m CNY	162.48 m CNY	164.16 m CNY	188.83 m CNY	124.18 m CNY
Research and development expense	73.57 m CNY	64.77 m CNY	61.09 m CNY	60.41 m CNY	53.71 m CNY
Selling, general and administrative expense	75.78 m CNY	78.58 m CNY	67.05 m CNY	77.77 m CNY	48.08 m CNY
Operating profit after depreciation	91.62 m CNY	80.51 m CNY	77.72 m CNY	18.25 m CNY	88.1 m CNY
Operating profit before depreciation	100.17 m CNY	88.56 m CNY	86.29 m CNY	26.98 m CNY	95.45 m CNY
EBIT	91.62 m CNY	80.51 m CNY	77.72 m CNY	18.25 m CNY	88.1 m CNY
EBITDA	100.17 m CNY	88.56 m CNY	86.29 m CNY	26.98 m CNY	95.45 m CNY
Interest expense	436 k CNY	621 k CNY	640 k CNY	412 k CNY	532 k CNY
Profit before tax	105.53 m CNY	120.15 m CNY	110.74 m CNY	54.47 m CNY	95.53 m CNY
Income tax expense	11.03 m CNY	8.33 m CNY	9.8 m CNY	261 k CNY	23.55 m CNY
Income before extraordinary items	93.44 m CNY	110.65 m CNY	102.03 m CNY	55.76 m CNY	78.81 m CNY
Common dividends	28 m CNY	50 m CNY	30 m CNY	15.44 m CNY	—
Total dividends	28 m CNY	50 m CNY	30 m CNY	15.44 m CNY	—

Quotes are end-of-day data. Content is for research purposes and is not investment advice.